Core Viewpoint - The recent issuance of a surgical robot charging guideline by the National Healthcare Security Administration is expected to benefit the surgical robot industry, leading to significant growth in both global and Chinese markets, particularly in the single-port and natural orifice robot segments [1] Group 1: Company Performance - Precision Medical-B (02675) saw its stock price increase by over 12%, reaching 64.85 HKD with a trading volume of 35.17 million HKD [1] - Since the commercialization of its multi-port laparoscopic surgical robot in December 2022, Precision Medical has sold 20 units in China by 2024, ranking first among domestic surgical robot manufacturers [1] Group 2: Industry Trends - The surgical robot industry is experiencing rapid growth due to technological innovation, clinical demand, and policy support, with a particular emphasis on the growth of domestic manufacturers in the import substitution and international expansion processes [1] - As of the end of 2025, Precision Medical has signed global sales agreements for 118 units of its core products, with 72 units designated for overseas markets, indicating a significant increase in international orders [1]
港股异动 | 精锋医疗-B(02675)午后涨超12% 公司国内厂商销量第一 海外订单量迎来爆发式增长